[go: up one dir, main page]

AU2002249042A1 - Individualization of therapy with hyperlipidemia agents - Google Patents

Individualization of therapy with hyperlipidemia agents

Info

Publication number
AU2002249042A1
AU2002249042A1 AU2002249042A AU2002249042A AU2002249042A1 AU 2002249042 A1 AU2002249042 A1 AU 2002249042A1 AU 2002249042 A AU2002249042 A AU 2002249042A AU 2002249042 A AU2002249042 A AU 2002249042A AU 2002249042 A1 AU2002249042 A1 AU 2002249042A1
Authority
AU
Australia
Prior art keywords
individualization
therapy
hyperlipidemia agents
hyperlipidemia
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249042A
Inventor
Brian Leyland-Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU2002249042A1 publication Critical patent/AU2002249042A1/en
Abandoned legal-status Critical Current

Links

AU2002249042A 2001-04-18 2002-04-17 Individualization of therapy with hyperlipidemia agents Abandoned AU2002249042A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/284,210 2001-04-18

Publications (1)

Publication Number Publication Date
AU2002249042A1 true AU2002249042A1 (en) 2002-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
AU2002322719A1 (en) Delivery of therapeutic capable agents
AU2002258063A1 (en) Medicament applicator
AU2003280262A1 (en) Individualization of therapy with anticoagulants
AU2002244568A1 (en) Individualization of therapy with antipsychotics
AU2002353739A1 (en) Therapeutic compounds
AU2002302223A1 (en) Individualization of therapy with analgesics
AUPR535101A0 (en) Novel therapeutic molecules
AU2002335667A1 (en) Modified reoviral therapy
AU2001273903A1 (en) Therapeutic agents
AU2002244575A1 (en) Individualization of therapy with antidepressants
AU2002349225A1 (en) Individualization of therapy with antiviral agents
AU2002257411A1 (en) Individualization of therapy with antineoplastic agents
AU2002257451A1 (en) Individualization of therapy with antibiotic agents
AU2002358574A1 (en) Therapeutic benzamide derivatives
AU2002350344A1 (en) Individualization of therapy with antihistamines
AU2002358076A1 (en) Therapeutic benzamide derivatives
AU2002249042A1 (en) Individualization of therapy with hyperlipidemia agents
AU2001292897A1 (en) Novel therapy
AU2002342488A1 (en) Individualization of therapy with anesthetics
AU2002250753A1 (en) Individualization of therapy with antiarrhythmics
AU2002333079A1 (en) Individualization of therapy with anxiolitics
AUPR713201A0 (en) Novel therapeutic molecules and uses therefor
AUPR946301A0 (en) Transdermal therapy
AU2002254577A1 (en) Trac1: modulators of lymphocyte activation